228 related articles for article (PubMed ID: 8050541)
1. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
Saadjian AY; Philip-Jöel FF; Barret A; Levy S; Arnaud AG
Eur Respir J; 1994 May; 7(5):862-8. PubMed ID: 8050541
[TBL] [Abstract][Full Text] [Related]
2. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of hypoxic pulmonary vasoconstriction by low dose almitrine bismesylate in normal humans.
Mélot C; Dechamps P; Hallemans R; Decroly P; Mols P
Am Rev Respir Dis; 1989 Jan; 139(1):111-9. PubMed ID: 2912330
[TBL] [Abstract][Full Text] [Related]
5. Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.
Górecka D; Sliwiński P; Pałasiewicz G; Pachocki R; Zieliński J;
Respiration; 2003; 70(3):275-83. PubMed ID: 12915747
[TBL] [Abstract][Full Text] [Related]
6. Restored hypoxic pulmonary vasoconstriction by peripheral chemoreceptor agonists in dogs.
Naeije R; Lejeune P; Vachiéry JL; Leeman M; Mélot C; Hallemans R; Delcroix M; Brimioulle S
Am Rev Respir Dis; 1990 Oct; 142(4):789-95. PubMed ID: 2121078
[TBL] [Abstract][Full Text] [Related]
7. [Long-term therapy with almitrine dimesilate has no effect on pulmonary hemodynamics at rest and during stress].
Böhning W; Winkelmann B; Worth H; Wettengel R; Brüch M; Breuer HW; Müller-Höhl ML; Nikolaus J
Pneumologie; 1990 Feb; 44 Suppl 1():444-5. PubMed ID: 2114628
[TBL] [Abstract][Full Text] [Related]
8. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
Weitzenblum E; Schrijen F; Apprill M; Prefaut C; Yernault JC
Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
[TBL] [Abstract][Full Text] [Related]
9. Long term studies on almitrine bismesylate in COPD patients.
Bourgouin-Karaouni D; Mercier J; Prefaut C
Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
[TBL] [Abstract][Full Text] [Related]
10. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
Castaing Y; Manier G; Varène N; Guénard H
Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
[TBL] [Abstract][Full Text] [Related]
12. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine inhibits the effects of almitrine in patients suffering from pulmonary artery hypertension secondary to chronic obstructive pulmonary disease.
Saadjian A; Philip-Joët F; Barret A; Levy S; Arnaud A
J Cardiovasc Pharmacol; 1993 May; 21(5):797-803. PubMed ID: 7685452
[TBL] [Abstract][Full Text] [Related]
14. Vascular and cardiac reactivity in pulmonary hypertension due to chronic obstructive lung disease: assessment with various oxygen concentrations.
Saadjian A; Philip-Joët F; Levy S; Arnaud A
Eur Respir J; 1992 May; 5(5):525-30. PubMed ID: 1612153
[TBL] [Abstract][Full Text] [Related]
15. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
de Backer W; Bogaert E; Van Maele R; Vermeire P
Eur J Respir Dis Suppl; 1983; 126():239-42. PubMed ID: 6426993
[TBL] [Abstract][Full Text] [Related]
16. Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise tolerance in hypoxemic patients with chronic obstructive pulmonary disease.
Ribeiro SA; Jardim JR; Romaldini H; Novo NF; Nery LE
Braz J Med Biol Res; 1995 Aug; 28(8):859-67. PubMed ID: 8555987
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
[TBL] [Abstract][Full Text] [Related]
18. Action of almitrine bismesylate on pulmonary vasculature in the dog: preliminary report.
Hughes JM; Allison DJ; Goatcher A; Tripathi A
Eur J Respir Dis Suppl; 1983; 126():215-24. PubMed ID: 6586436
[TBL] [Abstract][Full Text] [Related]
19. The acute effect of a single oral dose of 200 mg almitrine on gas exchange in patients with chronic obstructive bronchitis and emphysema, bronchial asthma and lung fibrosis.
Magnussen H; Radenbach D; Kiwull-Schöne H
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():211s-214s. PubMed ID: 3690032
[TBL] [Abstract][Full Text] [Related]
20. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
Bury T; Jeannot JP; Ansquer JC; Radermecker M
Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
